IRADIMED CORPORATION — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$2
Book Value Per Share
$7
Free Cash Flow Per Share
$1
Cash Per Share
$4
Revenue Per Share
$7
OCF Per Share
$2
Return on Equity
24.8%
Return on Assets
21.7%
Return on Invested Capital
22.8%
Current Ratio
7.98
Quick Ratio
6.84
Asset Turnover
0.81
Days Sales Outstanding
59.52
Days Payables Outstanding
34.08
Days Inventory On Hand
217.61
Cash Conversion Cycle
243.05
R&D / Revenue
3.5%
SBC / Revenue
3.5%
Capex / Revenue
9.3%
Working Capital
$71M
Net Current Asset Value
$67M
Invested Capital
$95M
OCF / Net Income
1.11
FCF / Net Income
0.76
Accruals Ratio (Sloan)
-2.3%
Net Debt
$-51M
Net Debt / EBITDA
-1.87
Dividend Coverage
1.66
Capex Coverage
3.21
Tangible Common Equity
$91M
TCE / Total Assets
83.9%
NOPAT
$21M
Cash ROIC
18.9%
WC / Revenue
84.7%
Capex / D&A
6.66
Reinvestment Rate
25.2%
Total Payout Ratio
66.9%
Asset Growth vs Revenue Growth
-3.8%
Revenue 5Y CAGR
21.5%
EPS 5Y CAGR
75.0%
FCF 5Y CAGR
26.2%
EBITDA 5Y CAGR
115.9%
Book Value 5Y CAGR
9.0%
Stock Price (FY-end)
$97
Market Cap
$1.25B
P/E Ratio
55.52
P/S Ratio
14.89
P/B Ratio
13.19
P/TB Ratio
13.68
P/OCF Ratio
50.03
P/FCF Ratio
72.64
Enterprise Value
$1.20B
EV / EBITDA
43.82
EV / Sales
14.28
EV / FCF
69.66
FCF Yield
1.4%
Dividend Yield
1.2%
Shareholder Yield
1.0%
Buyback Yield
—
R&D Yield
0.2%
Capex Yield
0.6%
Dividend Per Share
$1
DPS YoY Growth
9.4%
Operating Leverage
1.32
Graham Number
$17
Shares Variation (YoY)
0.5%
Beta (5Y)
0.88
Cost of Equity
8.9%
52W High
$98
52W Low
$48
Trailing Return 1Y
80.8%
Trailing Return 5Y
352.7%
F-Score (Piotroski)
5.00
Z-Score (Altman)
56.06
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.